Home/Filings/4/0000899243-22-006421
4//SEC Filing

Keane Raymond T 4

Accession 0000899243-22-006421

CIK 0001789972other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:48 PM ET

Size

7.5 KB

Accession

0000899243-22-006421

Insider Transaction Report

Form 4
Period: 2022-02-11
Keane Raymond T
Chief Legal Officer
Transactions
  • Award

    Common Stock

    2022-02-11+22,50024,124 total
  • Award

    Stock Option (Right to Buy)

    2022-02-11+45,00045,000 total
    Exercise: $13.60Exp: 2032-02-10Common Stock (45,000 underlying)
Footnotes (2)
  • [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
  • [F2]The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1
  • filerCIK 0001448434

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:48 PM ET
Size
7.5 KB